{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-036262","form_type":"8-K","ticker":"MIRA","cik":"0001904286","company_name":"MIRA PHARMACEUTICALS, INC.","filed_at":"2026-08-06T12:00:18+00:00","discovered_at":"2026-08-06T12:05:14.508599+00:00","generated_at":"2026-08-06T12:06:14.130926+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"MIRA reports positive 7-day dog study for obesity drug SKNY-1; de-risks dose selection","bullets":["SKNY-1 showed rapid oral absorption and dose-dependent systemic exposure in Beagle dogs over 7 days.","Plasma concentrations were comparable between male and female animals.","Data demonstrates dose-dependent response and systemic accumulation with repeated dosing.","Findings de-risk dose selection and support advancement toward GLP toxicology and IND-enabling studies.","SKNY-1 aims to preserve lean body mass while promoting weight reduction in obesity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-036262","json":"https://secwatch.observer/filing/0001493152-26-036262.json","markdown":"https://secwatch.observer/filing/0001493152-26-036262.md","text":"https://secwatch.observer/filing/0001493152-26-036262.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226036262/0001493152-26-036262-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1904286/000149315226036262/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T12:06:14.130926+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}